Project Twenty21 - Key Learnings

Missed the webcast with Professor David Nutt, Founder of Drug Science and Tejinder Virk, President of Khiron Europe?

There was lots to learn about how the two organizations are working together on Project Twenty21, Europes first and largest medical cannabis registry.

Khiron: Investment Highlights 2020

As Khiron shifts toward the sales-execution phase of its business plan, it is targeting markets it perceives as having the greatest near-term revenue potential and ROIC; these countries include Colombia, Brazil, Peru, the UK, and Germany, where sales have commenced or are expected.